Man­u­fac­tur­ing roundup: Astel­las to sell Dutch fa­cil­i­ty to Del­pharm; Au­ri­gene in­vest­ing $40M in­to In­dia man­u­fac­tur­ing fa­cil­i­ty

Astel­las Phar­ma is sell­ing its man­u­fac­tur­ing plant in Mep­pel, the Nether­lands, to con­tract man­u­fac­tur­er Del­pharm.

Astel­las said last week it’s trans­fer­ring the fa­cil­i­ty to Del­pharm as part of a wider shift for the phar­ma’s tech­nol­o­gy and man­u­fac­tur­ing busi­ness. As part of the deal, for which fi­nan­cial de­tails were not dis­closed, Del­pharm plans to con­tin­ue to pro­duce the prod­ucts that are made in the Mep­pel plant for Astel­las. The em­ploy­ees at the site will al­so trans­fer to Del­pharm as well. The deal is ex­pect­ed to close by the end of the year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER